0000876661-22-000756.txt : 20220915
0000876661-22-000756.hdr.sgml : 20220915
20220915155313
ACCESSION NUMBER: 0000876661-22-000756
CONFORMED SUBMISSION TYPE: 25-NSE
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20220915
DATE AS OF CHANGE: 20220915
EFFECTIVENESS DATE: 20220915
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: GLAXOSMITHKLINE CAPITAL INC
CENTRAL INDEX KEY: 0001224462
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34068
FILM NUMBER: 221245795
BUSINESS ADDRESS:
STREET 1: 1403 FOULK RD
STREET 2: SUITE 106
CITY: VILMINGTON
STATE: DE
ZIP: 19899-8985
BUSINESS PHONE: 3024795801
MAIL ADDRESS:
STREET 1: 1403 FOULK RD
STREET 2: SUITE 106
CITY: WILMINGTON
STATE: DE
ZIP: 19899-8985
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: NEW YORK STOCK EXCHANGE LLC
CENTRAL INDEX KEY: 0000876661
IRS NUMBER: 000000000
STATE OF INCORPORATION: NY
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: 11 WALL STREET
CITY: NEW YORK
STATE: NY
ZIP: 10005
BUSINESS PHONE: 212-656-2060
MAIL ADDRESS:
STREET 1: 11 WALL STREET
CITY: NEW YORK
STATE: NY
ZIP: 10005
FORMER COMPANY:
FORMER CONFORMED NAME: NEW YORK STOCK EXCHANGE INC
DATE OF NAME CHANGE: 19910628
25-NSE
1
primary_doc.xml
X0203
0000876661
NEW YORK STOCK EXCHANGE LLC
0001224462
GLAXOSMITHKLINE CAPITAL INC
001-34068
980 Great West Road
Brentford
TW8 9GS
+44 20 8047 5000
2.800% Notes due 2023
17 CFR 240.12d2-2(a)(1)
Victoria Paper
Manager, Market Watch and Proxy Compliance
2022-09-15
EX-99.25
2
ruleprovisionnotice.htm
NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES
The New York Stock Exchange hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on September 26, 2022, pursuant to the provisions of Rule 12d2-2 (a).
[ X ] 17 CFR 240.12d2-2(a)(1) That the entire class of this security was called for redemption, maturity or retirement on September 15, 2022; appropriate notice thereof was given; funds sufficient for the payment of all such securities were deposited with an agency authorized to make such payment; and such funds were made available to security holders on September 15, 2022.
The Exchange also notifies the Securities and Exchange Commission that as a result of the above indicated conditions this security was suspended from trading on September 15, 2022.